A new machine learning tool developed by a team of researchers led by Justin Reese of Berkeley Lab and Peter Robinson of Jackson Lab analyzes electronic health records to find symptoms in common between people who have been diagnosed with long COVID and to define subtypes of the condition.
Metformin May Mitigate More Severe COVID-19 Outcomes in Patients with Prediabetes, PCOS
An international team led by Justin Reese, a research scientist in the Environmental Genomics and Systems Biology (EGSB) Division, analyzed electronic health record data aggregated in the National COVID Cohort Collaborative (N3C) Data Enclave to assess whether metformin is associated with reduced COVID-19 severity in people with prediabetes or polycystic ovary syndrome (PCOS), two common conditions that increase the risk of severe COVID-19 presentation.
Was this page useful?
Send
